Schedule 13G ownership disclosure

Castle Biosciences Inc

Common Stock, $0.001 par value per share · CUSIP: 14843C105

Event date: 2025-04-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Portolan Capital Management, LLC

    Shares: 1,611,099.00 · Class: 5.65%

  • George McCabe

    Shares: 1,611,099.00 · Class: 5.65%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-034639
Form type
SCHEDULE 13G
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Apr 14, 2025
Reporting period
Apr 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub